OATP1B1 polymorphism as a determinant of erythromycin disposition.
Lancaster CS, Bruun GH, Peer CJ, Mikkelsen TS, Corydon TJ, Gibson AA, Hu S, Orwick SJ, Mathijssen RH, Figg WD, Baker SD, Sparreboom A.
Lancaster CS, et al. Among authors: peer cj.
Clin Pharmacol Ther. 2012 Nov;92(5):642-50. doi: 10.1038/clpt.2012.106. Epub 2012 Sep 19.
Clin Pharmacol Ther. 2012.
PMID: 22990751
Free PMC article.
Clinical Trial.